ZYME vs IBRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
ZYME
IBRX
Investment Advisor Scores
IBRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ZYME | IBRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 21.0526 | 70.922 | ZYME |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 828.7% | 52.3% | ZYME |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 48.2/100 | 39.7/100 | ZYME |
| Profit Margin | 16.3% | 0.0% | ZYME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | ZYME |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ZYME
NeutralMixed signals - no dominant trend phase, RSI 46
IBRX
NeutralMixed signals - no dominant trend phase, RSI 34
Fundamentals Snapshot
| Metric | ZYME | IBRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.9 | -91.0 |
| Trailing P/E | 59.4 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 8.3% | 0.5% |
| Gross Margin | 0.5% | 1.0% |
| Operating Margin | 0.7% | -1.6% |
| EPS | 0.53 | -1.06 |
| Dividend Yield | — | — |